NCT01265199 · Interventional trial
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)
Overall registry status Terminated
Phase 1
Conditions Acute Myelogenous Leukemia (AML)
Delaware Valley sites
- Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Temple University at Jeanes Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory